Akke-nynke G. Van Der Meer-Van Der Zon

Westernijkerk, FR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 30, 2025

Early Diagnosis and Treatment of COPD and Asthma.

Early Diagnosis and Treatment of COPD and Asthma.

Journal: The New England journal of medicine

Published: September 11, 2024

Summary of the Dutch Multidisciplinary Practice Guideline on Asthma and Pregnancy.

Summary of the Dutch Multidisciplinary Practice Guideline on Asthma and Pregnancy.

Journal: The journal of allergy and clinical immunology. In practice

Published: January 25, 2024

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice.

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice.

Journal: Frontiers in allergy

Published: December 13, 2023

Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed.

Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 01, 2021

Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study.

Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study.

Journal: International journal of clinical pharmacy

Published: September 02, 2021

Optimizing omalizumab dosing in severe asthma-the exploration of therapeutic drug monitoring.

Optimizing omalizumab dosing in severe asthma-the exploration of therapeutic drug monitoring.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 13, 2020

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial.

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial.

Journal: ERJ open research

Published: October 09, 2020

Dynamic hyperinflation impairs daily life activity in asthma.

Dynamic hyperinflation impairs daily life activity in asthma.

Journal: The European respiratory journal

Published: August 07, 2018

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 29, 2017

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 06, 2017

A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.

A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.

Journal: The European respiratory journal

Published: January 29, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026